On April 30, 2026, Context Therapeutics Inc. reported that they have settled a stockholder class action lawsuit, agreeing to pay $850,000 in fees. This settlement resolves claims related to corporate governance issues, with case closure expected after the company's annual meeting on June 24, 2026.